Related Experiment Videos

p21Waf1 inhibits the activity of cyclin dependent kinase 2 by preventing its activating phosphorylation

M Hitomi1, J Shu, M Agarwal

  • 1The Department of Molecular Biology, The Lerner Research Institute, The Cleveland Clinic Foundation, Ohio 44195, USA.

Oncogene
|September 25, 1998
PubMed

Insights

Prostaglandin A2 (PGA2) inhibits cell growth by blocking cyclin-dependent kinase 2 (cdk2) activation. This effect is dependent on the protein p21Waf1, which prevents cdk2 phosphorylation and activation.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Molecular Biology

Background:

  • Prostaglandin A2 (PGA2) is a known inhibitor of cell proliferation.
  • Cyclin-dependent kinases (cdks) regulate the cell cycle.
  • p21Waf1 is a cyclin-dependent kinase inhibitor.

Purpose of the Study:

  • To investigate the mechanism by which Prostaglandin A2 (PGA2) inhibits cell growth.
  • To determine the role of cyclin-dependent kinase 2 (cdk2) and p21Waf1 in PGA2-induced growth inhibition.

Main Methods:

  • Kinetic studies of cdk2 activation and phosphorylation.
  • Analysis of cyclin D1 and p21Waf1 levels.
  • Experiments using p21Waf1 knockout (p21Waf1(-/-)) and wild-type (p21Waf1(+/+)) cells.

Main Results:

  • PGA2 suppressed cyclin D1 and elevated p21Waf1 levels.
  • Inhibition of cdk2 activation by phosphorylation correlated with growth inhibition.
  • p21Waf1 levels increased prior to cdk2 phosphorylation, suggesting p21Waf1 blocked this process.
  • PGA2 failed to inhibit cdk2 activation and cell growth in p21Waf1 knockout cells.

Conclusions:

  • PGA2 inhibits cell growth primarily by preventing the activating phosphorylation of cdk2.
  • The protein p21Waf1 is essential for PGA2's inhibitory effect on cdk2 activation and cell proliferation.
  • These findings elucidate a key molecular mechanism of PGA2 action in cell cycle regulation.

Related Concept Videos